FR2944805B1 - Signature moleculaire pronostique des sarcomes et utilisations - Google Patents

Signature moleculaire pronostique des sarcomes et utilisations Download PDF

Info

Publication number
FR2944805B1
FR2944805B1 FR0901936A FR0901936A FR2944805B1 FR 2944805 B1 FR2944805 B1 FR 2944805B1 FR 0901936 A FR0901936 A FR 0901936A FR 0901936 A FR0901936 A FR 0901936A FR 2944805 B1 FR2944805 B1 FR 2944805B1
Authority
FR
France
Prior art keywords
sarcomes
molecular signature
prognostic molecular
prognostic
signature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0901936A
Other languages
English (en)
Other versions
FR2944805A1 (fr
Inventor
Frederic Chibon
Jean Michel Coindre
Alain Aurias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Bergognie Fr
Universite Bordeaux Segalen
Original Assignee
INST BERGOGNIE
Universite Victor Segalen Bordeaux 2
Universite Bordeaux Segalen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST BERGOGNIE, Universite Victor Segalen Bordeaux 2, Universite Bordeaux Segalen filed Critical INST BERGOGNIE
Priority to FR0901936A priority Critical patent/FR2944805B1/fr
Priority to JP2012506544A priority patent/JP5865241B2/ja
Priority to PCT/FR2010/000323 priority patent/WO2010122243A1/fr
Priority to CA2759417A priority patent/CA2759417C/fr
Priority to EP10718241A priority patent/EP2473622A1/fr
Priority to US13/265,764 priority patent/US9708666B2/en
Publication of FR2944805A1 publication Critical patent/FR2944805A1/fr
Application granted granted Critical
Publication of FR2944805B1 publication Critical patent/FR2944805B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0901936A 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations Expired - Fee Related FR2944805B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0901936A FR2944805B1 (fr) 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations
JP2012506544A JP5865241B2 (ja) 2009-04-22 2010-04-21 肉腫の予後分子署名およびその使用
PCT/FR2010/000323 WO2010122243A1 (fr) 2009-04-22 2010-04-21 Signature moléculaire pronostique des sarcomes et utilisations
CA2759417A CA2759417C (fr) 2009-04-22 2010-04-21 Signature moleculaire pronostique des sarcomes et utilisations
EP10718241A EP2473622A1 (fr) 2009-04-22 2010-04-21 Signature moléculaire pronostique des sarcomes et utilisations
US13/265,764 US9708666B2 (en) 2009-04-22 2010-04-21 Prognostic molecular signature of sarcomas, and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901936 2009-04-22
FR0901936A FR2944805B1 (fr) 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations

Publications (2)

Publication Number Publication Date
FR2944805A1 FR2944805A1 (fr) 2010-10-29
FR2944805B1 true FR2944805B1 (fr) 2018-04-06

Family

ID=42077215

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0901936A Expired - Fee Related FR2944805B1 (fr) 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations

Country Status (6)

Country Link
US (1) US9708666B2 (fr)
EP (1) EP2473622A1 (fr)
JP (1) JP5865241B2 (fr)
CA (1) CA2759417C (fr)
FR (1) FR2944805B1 (fr)
WO (1) WO2010122243A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3064594A1 (fr) 2015-03-06 2016-09-07 Université de Bordeaux Signature de résultat clinique dans l'analyse de tumeurs du muscle lisse de la paroi utérine et procédé de diagnostic de celui-ci
WO2017210662A1 (fr) * 2016-06-03 2017-12-07 Castle Biosciences, Inc. Procédés de prédiction du risque de récurrence et/ou de métastases dans le sarcome des tissus mous
RU2625035C1 (ru) * 2016-09-06 2017-07-11 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ прогнозирования рецидивирования сарком мягких тканей
EP3530758A1 (fr) 2018-02-23 2019-08-28 Université de Bordeaux Procédé pour déterminer la présence in vitro d'une molécule cible dans un échantillon biologique et son utilisation pour l'analyse in vitro de cancers, en particulier de sarcomes des tissus mous et de tumeurs stromales gastro-intestinales

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295328A1 (en) * 2002-10-02 2004-04-23 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20040253606A1 (en) * 2002-11-26 2004-12-16 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
EP1766091A4 (fr) * 2004-05-27 2009-03-18 Vertex Pharma Biomarqueurs pour le suivi d'inhibition de la voie de l'inosine monophosphate deshydrogenase (impdh)
EP1806413A1 (fr) * 2006-01-06 2007-07-11 Oligene GmbH Procédé in vitro et outiles pour la détection des differents types de tumeur et prédiction des résultats d'intervention chirurgical du cancer de l'ovaire
US8130007B2 (en) * 2006-10-16 2012-03-06 Formfactor, Inc. Probe card assembly with carbon nanotube probes having a spring mechanism therein

Also Published As

Publication number Publication date
US9708666B2 (en) 2017-07-18
WO2010122243A1 (fr) 2010-10-28
EP2473622A1 (fr) 2012-07-11
JP5865241B2 (ja) 2016-02-17
CA2759417C (fr) 2018-05-08
JP2012524537A (ja) 2012-10-18
US20130065772A1 (en) 2013-03-14
CA2759417A1 (fr) 2010-10-28
FR2944805A1 (fr) 2010-10-29

Similar Documents

Publication Publication Date Title
BRPI1007612A2 (pt) instalação de centro de dados e centro de dados
BRPI1007533A2 (pt) prevencao de cartao falso-positiva
BR112012002877A2 (pt) dilatador e conjunto.
BRPI1012904A2 (pt) centro de dados
BRPI0920897A2 (pt) prognóstico e prevenção de pré-eclampsia
FR2953220B1 (fr) Signature microarn de la differenciation epidermique et utilisations
BR112013009680A2 (pt) dispositivo de autenticação de verificação, e, dispositivo periférico de computador
DK2491681T3 (da) Bygningsautomatiserings- og bygningsinformationssystem
BRPI0921938A2 (pt) acionamento de ações de animação e ações de objeto de mídia
DK3103478T3 (da) Stabiliserede fibronektin-domænesammensætninger, fremgangsmåder og anvendelser
BRPI0913933A2 (pt) polímeros modificados com silanos
BRPI1006166A2 (pt) gestos padrão.
BRPI0923191A2 (pt) metodos relacionados com glicanos modificados
BRPI0920736A2 (pt) módulo de placa e método de fabricação do mesmo.
BRPI1016117A8 (pt) derivados de isoxazol-isoxazol e isoxazol-isotiazol.
BR112012004774A2 (pt) polímero e processo
BR112012003717A2 (pt) painéis de chapa de gesso e métodos de produção dos mesmos
FR2944805B1 (fr) Signature moleculaire pronostique des sarcomes et utilisations
FR2968201B1 (fr) Complexe saspase-flg2, agents modulateurs et utilisations
FR2957492B1 (fr) Nouvelles utilisations de composes de type esteramide
ITBO20080033A1 (it) Tutore
BRPI1014177A2 (pt) estado de domínio, propósito e categorias
FR2943345B1 (fr) Analogues de la temporine-sha et leurs utilisations
FR2949865B1 (fr) Autodiagnostic de calculateurs mecatroniques
DK2310037T3 (da) Conglutin-gamma as-medikament og -kosttilskudpatentkrav

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: UNIVERSITE BORDEAUX SEGALEN, FR

Effective date: 20111108

Owner name: INSTITUT BERGOGNIE, FR

Effective date: 20111108

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20211205